Furthermore, in a phase 2 clinical trial addressing a patient group with type 2 diabetes and overweight/obesity, after 32 weeks of treatment, the cagrisema 2.4 mg group exhibited a more significant average weight loss compared to the cagrilintide 2.4 mg group or the group using semaglutide 2.4 mg alone, with reductions of 15.6%, 8.1%, and 5.1%, respectively
Remember, losing just 5 to 10% of your body weight can significantly improve many aspects of your health. It can also be encouraging to look at other non-scale wins, as Shapiro refers to them, such as your clothing fitting better or being able to climb stairs more easily
Key Facts Ulrich Otte, Novo Nordisks senior vice president of finance & operations, said at the Cantor Global Healthcare Conference on Tuesday that it is very likely Ozempic will be part of cost negotiations organized by the US Centers for Medicare and Medicaid Services, adding Novo Nordisk is ready for that, Bloomberg reported
Three areas of the body are approved for semaglutide injections: The abdomen
Additionally, it helps reduce appetite and promote weight loss in people who are obese or overweight